Disclosure Of Material Accounting Policy Information [Text Block]

ERYTECH Pharma S.A. - Filing #2810992

Concept	2023-01-01 to 2023-12-31
Disclosure of material accounting policy information [text block]
Description of accounting policy for deferred income tax [text block]
Description of accounting policy for depreciation expense [text block]
Description of accounting policy for derecognition of financial instruments [text block]
Description of accounting policy for determining components of cash and cash equivalents [text block]
Description of accounting policy for earnings per share [text block]
Description of accounting policy for employee benefits [text block]
Description of accounting policy for fair value measurement [text block]
Description of accounting policy for finance income and costs [text block]	Méthodes comptables
Description of accounting policy for financial assets [text block]
Description of accounting policy for financial instruments [text block]	Méthodes comptables
Description of accounting policy for goodwill [text block]
Description of accounting policy for government grants [text block]	Crédit d’impôt recherche
Description of accounting policy for income tax [text block]
Description of accounting policy for issued capital [text block]
Description of accounting policy for leases [text block]
Description of accounting policy for provisions [text block]
Description of accounting policy for recognition of revenue [text block]	Revenus liés à des licences ou d’autres contrats
Description of accounting policy for research and development expense [text block]
Description of accounting policy for segment reporting [text block]
Description of accounting policy for share-based payment transactions [text block]	Méthodes comptables
Description of accounting policy for trade and other receivables [text block]